ACADIA Pharmaceuticals (ACAD) Earnings Date & Reports

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ACAD is expected to report earnings to rise 40.64% to 15 cents per share on July 30

ACADIA Pharmaceuticals ACAD Stock Earnings Reports

Q2'25

Est.

$0.15

Q1'25

Beat

by $0.13

Q4'24

Beat

by $0.64

Q3'24

Beat

by $0.06

Q2'24

Beat

by $0.02

The last earnings report on May 07 showed earnings per share of 10 cents, beating the estimate of -1 cents. With 2.86M shares outstanding, the current market capitalization sits at 2.91B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+30%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

ACAD